-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$26.322.85% Upside
Deciphera Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Deciphera Pharmaceuticals, Inc.?
Deciphera Pharmaceuticals, Inc. has been rated by research analysts at Barclays, Jefferies, Raymond James, Leerink Partners, H.C. Wainwright in the past 90 days.